In Episode 20, Season 3 of the Amplifying Scientific Innovation Video Podcast, Dr. Sophia Ononye-Onyia, Founder and CEO of The Sophia Consulting Firm, interviewed Mr. Craig Lipset, Advisor and Founder of Clinical Innovation Partners and former Head of Clinical Innovation at Pfizer. Here, Mr. Lipset discusses his commitment to bringing vision and driving action at the intersection of diverse research, digital solutions, and data-enabled patient engagement. For full transcript, please visit: https://sophiaconsultingfirm.com/blogs-%2B-articles/f/amplifying-scientific-innovation-craig-lipset
On the show today —> The venerable Craig Lipset, a storied luminary in the annals of clinical trial innovation — and I mean innovation with a Capital I. (None of that lower case crap happening here on my watch) Craig is the Founder of Clinical Innovation Partners and the Co-Founder of Decentralized Trials & Research Alliance (DTRA), and a proud expatriated Long Islander who pronounces Rutgers the proper way and has a penchant for Wegmans. He ticks every box. He's also been at the literal forefront of clinical trial research and development for over 30 years. Warning that the following episode may contain explicit acronyms and an overdose of syllables.
Craig Lipset is the founder of Clinical Innovation Partners, providing advisory and board leadership with pharma, tech and venture capital to bring vision and driving action at the intersection of research, digital solutions, and patient engagement. He is co-chair for the Decentralized Trials & Research Alliance, serves on the Board of Directors for the Foundation for Sarcoidosis Research and the MedStar Health Research Institute, as well as on the Editorial Board for Therapeutic Innovation & Regulatory Science. Craig is Adjunct Assistant Professor in Health Informatics at Rutgers University, and Adjunct Instructor in the Center for Health + Technology at University of Rochester. Craig was the Head of Clinical Innovation and Venture Partner at Pfizer, on the founding Operations Committee for TransCelerate Biopharma, and on the founding management teams for two successful startup ventures.Craig has been listed among the PharmaVOICE most inspiring people in the life sciences (Red Jacket hall-of-fame), Pharmaceutical Executive’s Emerging Leaders, CenterWatch Top 20 Innovators in Clinical Trials, and the AlleyWatch Who's Who in eHealth.
2021 and Beyond – The Changing Role of Data in Clinical Trials: An Interview With Craig Lipset, Artem Andrianov, and Moe Alsumidaie
The COVID-19 pandemic has rapidly transformed the clinical trials landscape. What is happening to data as clinical trials become increasingly decentralized? Join Darshan Kulkarni as he talks with guests Craig Lipset, Artem Andrianov and Moe Alsumidaie about the new role of data in clinical trials. Plus, we’ll discuss the advantages of risk based monitoring.
Series 2 Episode 1 – Craig Lipset Leader & Innovator in the World of Clinical Trials and Medicine development.
The Huxley Morton Podcast
This week we kick off the New Year with a New Series of The Huxley Morton Podcast and speak to one of the biggest influencers in Clinical Research and Medicine Development Craig Lipset. Craig has been one step ahead of the game when it comes to innovation and technology so when the world turned on its head in 2020 Craig was ready to help and advice clients on how to navigate their studies and promote the movement towards decentralized trials. Tune in to hear how Craig started out in the industry including his 12 years at Pfizer as their Head of Clinical innovation and how growing his network via LinkedIn has led to several exciting opportunities and has enabled Craig to spearhead so many amazing new Ventures. We finish this week’s podcast hearing about Craig’s predictions for the future of clinical trials and hear his thoughts on the new Vaccines that are getting released as we speak.
Craig Lipset on Clinical Research in a 2020 and Beyond World Ep.453
Random Musings From The Clinical Trials Guru
Craig's LinkedIn: https://www.linkedin.com/in/lipset/ Text Me: (949) 415-6256 My podcast is Random Musings From The Clinical Trials Guru Listen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7a GET THE BOOK! https://www.amazon.com/dp/1090349521/... Text "guru" to 31996 to join VIP list! My blog: http://www.TheClinicalTrialsGuru.com My business Patreon Page: http://www.patreon.com/dansfera My CRO and Site Network: http://www.DSCScro.com My CRA Academy: http://www.TheCRAacademy.com My CRC Academy: http://www.TheCRCacademy.com
Innovation in Research, Digital Solutions and Patient Engagement with Craig Lipset from Clinical Innovation Partners
Healthcare Goes Digital
Craig Lipset, Founder and Advisor at Clinical Innovation Partners and former Head of Clinical Innovation and Venture Partner at Pfizer, discusses everything from his personal health journey to his professional accomplishments, including the journey from the corporate world to being his own boss. We also discuss decentralized trials, and how COVID-19 is accelerating the uptake of these and the ability of patients to make their own informed decisions. Other innovative concepts such as e-patients, novel clinical trial endpoints, passive data collection, and beyond-the-pill thinking are also explored.Schedule a meeting with Natalie Yeadon: https://www.meetwithnatalie.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: https://www.impetusdigital.com/Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/Impetus Digital Twitter: https://twitter.com/ImpetusadboardsImpetus YouTube: https://www.youtube.com/ImpetushealthcareCraig Lipset: https://www.linkedin.com/in/lipset/Clinical Innovation Partner: https://www.linkedin.com/company/clinicalinnovation/
Tech Tonics: Craig Lipset – Patient-Centric Before It Was Cool
As a boy, Craig Lipset thought he wanted to become a doctor – but over time, he came to appreciate that his real interest was, as he put it, engaging in the spirit of medicine at the population level – a pursuit that ultimately brought him to the forefront of digital health at Pfizer, establishing a capability long before most pharmas even recognized they needed it. Craig grew up in the distinct cultural milieu that is the North Shore of Long Island. A middle child with an interest in music and medicine, he attended Brandeis, where he majored in music, took pre-med classes, and worked for an EMS service in Waltham, MA. In 1992 he returned to New York, and obtained an MPH at Columbia, and discovered he loved thinking about populations, and wanted to learn more about the organizations helping to study them. After graduation in 1998, he considered consulting, but instead joined a contract research organization, Parexel and worked closely with Dr. Mark Goldberg, who would go on to become the President and COO. He eventually left Parexel to join a VC-backed company in Waltham that was ultimately acquired by Bristol Myers Squibb. At around this time, Craig’s life changed dramatically and unexpectedly when he was diagnosed with pulmonary sarcoidosis. He decided to make a life change, so he returned to the New York area and joined Pfizer in 2006, where he would stay for eleven years. Craig built their clinical innovation program from a footnote to a core business capability. Within a year of joining Pfizer, Craig began to apply his personal experience as an e-patient and was designing the industry’s first fully at-home decentralized clinical trial – the Pfizer REMOTE study. During his tenure, Pfizer — along with the rest of the industry –would increasingly begin to appreciate the value of digital and the opportunity for patient-centricity that Craig had been championing so passionately for years. Today, Craig serves as an independent adviser, sharing his experience, expertise, and learnings with biopharma companies, startups, and investors.